Symbol Lookup

Monday April 21, 2014 5:37 AM ET. Data delayed 15 minutes.
0.22
0.00 (0.00%)
Bid/Lots
0.22/25
Ask/Lots
0.23/25
Open/Prev Close
0.00/0.22
Day Range
-----
52-Week Range
0.08-0.35
Vol/Avg Daily Vol
0.0/954.9K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
CytoSorbents Expands Distribution to the Vast Middle Eastern Market of Saudi Arabia, United Arab Emirates, and Other GCC Countries with Techno Orbits
8:00AM ET on Tuesday Apr 08, 2014 by PR Newswire

CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses, announced distribution of its CytoSorb(R) extracorporeal cytokine filter in the Middle East, including S...

CytoSorbents to Present at the 13th Annual Needham Healthcare Conference
8:30AM ET on Thursday Apr 03, 2014 by PR Newswire

CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life threatening conditions in the intensive care unit, announced that Dr. Phillip Chan, MD, PhD, Chief Executive Officer of CytoSor...

CytoSorbents Posts Record Q4 2013 and Full Year 2013 Revenue
4:05PM ET on Monday Mar 31, 2014 by PR Newswire

CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses in the intensive care unit, provides an operational summary and financial results for the fiscal year end...

CytoSorbents to Report Fiscal 2013 Operating and Financial Results
7:00AM ET on Tuesday Mar 25, 2014 by PR Newswire

CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb(R) blood filter to treat life-threatening illnesses in the intensive care unit, will report fiscal 2013 financial...

Company Information

CytoSorbents Corporation is a development stage critical care focused company using blood purification to treat life-threatening illnesses. The technology is based upon biocompatible, highly porous polymer sorbent beads that are capable of extracting unwanted substances, such as drugs, dangerous chemicals, toxins, cytokines, free hemoglobin, and antibodies, from blood and other bodily fluids. Its CE Mark enables CytoSorb to be sold throughout the entire European Union. In addition to the sepsis indication, the Company continues to foster research in other critical care illnesses where CytoSorb could be used, such as ARDS, trauma, severe burn injury, acute pancreatitis, and in other acute conditions that may benefit by the reduction of cytokines in the bloodstream.

CONTACT INFORMATION

HeadquartersSuite K, 7 Deer Park Drive
MONMOUTH JUNCTION, NJ, United States 08852
Phone732-329-8885
Fax732-329-8650

EXECUTIVE OFFICERS

Chairman of the BoardAl Kraus
President, Chief Executive Officer, DirectorPhillip Chan
Chief Financial OfficerKathleen Bloch
Chief Operating OfficerVincent Capponi
Chief Medical OfficerRobert Bartlett

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$65.7MBeta0.50
Revenue (TTM)$2.1MEPS$-0.03
Shares Out.298.6MBook Value$0.01
Cytosorbents Corp does not pay a dividend.P/E--
Price/Sales (TTM)30.6
P/Cash Flow (TTM)--
Operating Margin-210.53%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample